Parsons James T. — SEC Form 4 filings
SEC reporting owner CIK 1759855. 8 Form 4 filings on record with FilingPulse; latest filed 2026-06-03.
Transaction summary — filings shown
Covers all 8 filings on record, filed 2024-06-03 to 2026-06-03. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 1 leg across 1 filing — 10,000 shares, $10,300 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 9.
- Largest priced transaction: purchase of 10,000 shares @ $1.03 ($10,300) in ONCOLYTICS BIOTECH INC, filed 2026-03-13.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| ONCOLYTICS BIOTECH INC (ONCY) | Director | 2 | 1 leg · 10,000 sh · $10,300 | — | 1 |
| DiaMedica Therapeutics Inc. (DMAC) | Director | 6 | — | — | 8 |
Form 4 filings — Parsons James T.
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-03 | 4 | ONCOLYTICS BIOTECH INC (ONCY) | Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
| 2026-06-03 | 4 | DiaMedica Therapeutics Inc. (DMAC) | Grant/award (A): 51,189 (derivative) @ $0 | EDGAR |
| 2026-03-13 | 4 | ONCOLYTICS BIOTECH INC (ONCY) | Purchase (P): 10,000 @ $1.03 | EDGAR |
| 2026-01-06 | 4 | DiaMedica Therapeutics Inc. (DMAC) | Grant/award (A): 10,095 @ $8.42 | EDGAR |
| 2025-11-25 | 4 | DiaMedica Therapeutics Inc. (DMAC) | Option exercise (M): 12,000 @ $2.20 · Option exercise (M): 12,000 (derivative) @ $0 | EDGAR |
| 2025-06-03 | 4 | DiaMedica Therapeutics Inc. (DMAC) | Grant/award (A): 40,739 (derivative) @ $0 | EDGAR |
| 2025-01-03 | 4 | DiaMedica Therapeutics Inc. (DMAC) | Grant/award (A): 15,917 @ $5.34 · Grant/award (A): 4,287 (derivative) @ $0 | EDGAR |
| 2024-06-03 | 4 | DiaMedica Therapeutics Inc. (DMAC) | Grant/award (A): 28,472 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1759855 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →